Sugammadex Side Effects
Medically reviewed by Drugs.com. Last updated on Nov 24, 2024.
Applies to sugammadex: intravenous solution.
Precautions
It is important that your doctor check your progress closely while you or your child are receiving this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to receive it. Blood tests may be needed to check for unwanted effects.
Birth control pills may not work as well to prevent pregnancy when used with this medicine. Use another form of birth control, including condoms and spermicides along with your pills. Use an effective form of birth control for at least 7 days after receiving sugammadex.
This medicine may cause serious allergic reactions including anaphylaxis, which can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have a rash, itching, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth while you are using this medicine.
Bradycardia may occur after receiving this medicine. Tell your doctor right away if you have chest pain or discomfort, lightheadedness, dizziness or fainting, slow or irregular heartbeat, trouble breathing, or unusual tiredness.
This medicine may increase your risk of bleeding problems. Tell your doctor right away if you have sudden or severe headache, problems with vision, speech, or walking, or unusual bleeding or bruising.
Before you have any medical tests, tell the medical doctor in charge that you were given this medicine. The results of some tests may be affected by this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of sugammadex
Along with its needed effects, sugammadex may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking sugammadex:
More common side effects
- blurred vision
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- headache
- nervousness
- pounding in the ears
- slow or fast heartbeat
- sweating
- unusual tiredness or weakness
Less common side effects
- chest pain or discomfort
- chills
- fever
- trouble breathing
Incidence not known
- blue lips and fingernails
- confusion
- cough
- difficult, fast, noisy breathing
- difficulty with breathing
- difficulty with swallowing
- feeling of warmth
- hives or welts, itching, or rash
- hoarseness
- increased sweating
- irritation
- joint pain, stiffness, or swelling
- pale skin
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- redness of the face, neck, arms, and occasionally, upper chest
- severe, sudden headache
- swelling in the legs and ankles
- unusual bleeding or bruising
Other side effects of sugammadex
Some side effects of sugammadex may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- cough
- headache
- nausea
- pain at the injection site
- pain in the arms or legs
- stomach pain
- vomiting
Less common side effects
- bloated
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- dry mouth
- feeling sad or empty
- full feeling
- irritability
- joint or muscle pain
- lack of appetite
- loss of interest or pleasure
- passing gas
- restlessness
- sore throat
- tiredness
- trouble concentrating
- trouble sleeping
For healthcare professionals
Applies to sugammadex: intravenous solution.
General adverse events
The most commonly reported adverse reactions have included vomiting, pain, nausea, hypotension and headache.[Ref]
Cardiovascular
- Common (1% to 10%): Abnormal ECG, hypertension, hypotension, tachycardia, bradycardia, abnormal or prolonged QT interval
- Postmarketing reports: Bradycardia with cardiac arrest, atrial fibrillation, atrioventricular block, cardiac/cardiorespiratory arrest, ST segment changes, supraventricular tachycardia/extrasystoles, tachycardia, ventricular fibrillation, and ventricular tachycardia[Ref]
Cases of marked bradycardia, some resulting in cardiac arrest, have occurred within minutes of administering this drug. Cardiac electrophysiology studies have shown that at 2 times the maximum recommended dose, the QT interval was not prolonged to any clinically relevant extent.[Ref]
Hypersensitivity
- Uncommon (0.1% to 1%): Anaphylaxis, hypersensitivity reactions
- Postmarketing reports: Anaphylactic shock, anaphylactic reaction, anaphylactoid reaction, Type I hypersensitivity[Ref]
In a dedicated hypersensitivity study in healthy volunteers, anaphylaxis occurred in 1 of 299 patients (0.3%). This patient experienced anaphylaxis with the first dose (16 mg/kg) and symptoms included conjunctival edema, urticaria, erythema, swelling of the uvula, and reduction in peak expiratory flow. Hypersensitivity reactions including nausea, pruritus, and urticaria occurred in a dose-related manner with more reactions occurring in the 16 mg/kg dose group compared to the 4 mg/kg group.
Anaphylaxis has been reported at all doses. The most commonly described reactions included in reports of anaphylaxis have included dermatologic reactions (e.g., urticaria, rash, erythema, flushing, and skin eruption), and clinically important hypotension often requiring vasopressors for circulatory support. There have also been reports of prolonged hospitalization with the use of additional respiratory support in some patients.[Ref]
Gastrointestinal
- Common (1% to 10%): Nausea (up to 26%), vomiting (up to 15%)
- Uncommon (0.1% to 1%): Abdominal pain, flatulence, dry mouth[Ref]
Respiratory
- Common (1% to 10%): Airway complication of anesthesia, oropharyngeal pain, cough
- Frequency not reported: Bronchospasm
- Postmarketing reports: Laryngospasm, dyspnea, wheezing, pulmonary edema, respiratory arrest[Ref]
Bronchospasm was observed in patients with a history of pulmonary complications.[Ref]
Dermatologic
- Common (1% to 10%): Pruritus, erythema[Ref]
Hematologic
- Common (1% to 10%): Decreased red blood cell count, hematoma, anemia[Ref]
Local
- Common (1% to 10%): Injection site pain[Ref]
Metabolic
- Common (1% to 10%): Hypocalcemia[Ref]
Musculoskeletal
- Common (1% to 10%): Extremity pain, musculoskeletal pain, myalgia, creatine phosphokinase increased[Ref]
Nervous system
- Common (1% to 10%): Headache, dizziness, hypoesthesia, dysgeusia[Ref]
Other
- Very common (10% or more): Pain (up to 52%)
- Common (1% to 10%): Procedural complication, anesthetic complication, wound hemorrhage, pyrexia, chills, ear and labyrinth disorders
- Uncommon (0.1% to 1%): Recurrence of neuromuscular blockade[Ref]
In clinical studies using this drug at doses labeled for the depth of neuromuscular blockade (n=2022), less than 1% of patients were observed to have recurrence of neuromuscular blockade as based on neuromuscular monitoring or clinical evidence.
Airway complications of anesthesia have included bucking against the endotracheal tube, coughing, mild bucking, arousal reaction during surgery, coughing during the anesthetic procedure or during surgery, or anesthetic procedure related spontaneous breath of patient. Anesthetic complications include reports of the restoration of neuromuscular function (e.g., movement of limb or body, grimacing, or suckling on the endotracheal tube). Procedural complications include coughing, tachycardia, bradycardia, movement, and increased heart rate.[Ref]
Psychiatric
- Common (1% to 10%): Insomnia, anxiety, restlessness, depression, sleep disorder[Ref]
See also:
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Bridion
Bridion is used for reversal of neuromuscular blockade, reversal of nondepolarizing muscle relaxants
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Regonol
Regonol is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Prostigmin Bromide
Prostigmin Bromide is used for myasthenia gravis, urinary retention
Glycopyrrolate/neostigmine
Glycopyrrolate/neostigmine systemic is used for reversal of neuromuscular blockade
Edrophonium
Edrophonium systemic is used for reversal of nondepolarizing muscle relaxants
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2015) "Product Information. Bridion (sugammadex)." Merck & Co., Inc
More about sugammadex
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Sugammadex side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.